🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakiz...
Status
Active Not Recruiting
Location
Smary Cures Clinical Research
Start Date
2025-03-21
Trial ID
NCT06611163
Treatments Being Tested
This is a phase Ⅲ, randomized, double-blind, placebo-controlled, parallel d...
Status
Completed
Location
The First Affiliated Hospital of Air Force Medical University of PLA
Start Date
2020-12-17
Trial ID
NCT05108766
Treatments Being Tested
Design: Single-center open-label clinical trial. Objective: Evaluate if ti...
Status
Completed
Location
Clinical Trials Center for Skin Diseases: Rhode Island Hospital, 593 Eddy Street, Dermatology Research, Jane Brown Building, 1st floor, Room 115
Start Date
2022-04-08
Trial ID
NCT05110313
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The main aim of the study is to evaluate the efficacy, safety and impact on...
Status
Completed
Location
Investigator Site 9
Start Date
2019-12-17
Trial ID
NCT04229836
Treatments Being Tested
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-05
Trial ID
NCT01729754
This is a phase 2 open-label trial designed to evaluate the efficacy of til...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2020-03-01
Trial ID
NCT04112810
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
Investigator Site 3
Start Date
2019-09-04
Trial ID
NCT04263610
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01936688
Treatments Being Tested
This is an open-label, pilot study evaluating the efficacy of tildrakizumab...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04465292
Treatments Being Tested